A patient with hepatocellular carcinoma who developed invasive pulmonary
aspergillosis after corticosteroid treatment
- Shintaro Sato
, - Sho Yamada,
- Tomotaka Nishizawa,
- Tomohiro Oba,
- Rie Kawabe,
- Hideaki Yamakawa,
- Keiichi Akasaka,
- Masako Amano,
- Hidekazu Matsushima
Abstract
Corticosteroid administration can be a trigger of the onset of invasive
pulmonary aspergillosis in patients with hepatocellular carcinoma. It is
necessary to pay attention to the presence of cirrhosis, which may be
the basis of hepatocellular carcinoma especially when administering
systemic corticosteroid.25 Dec 2020Submitted to Clinical Case Reports 25 Feb 2021Submission Checks Completed
25 Feb 2021Assigned to Editor
03 Mar 2021Reviewer(s) Assigned
15 Jun 2021Review(s) Completed, Editorial Evaluation Pending
15 Jun 2021Editorial Decision: Revise Minor
17 Jun 20211st Revision Received
18 Jun 2021Submission Checks Completed
18 Jun 2021Assigned to Editor
18 Jun 2021Review(s) Completed, Editorial Evaluation Pending
06 Jul 2021Editorial Decision: Accept
